Le Lézard
Classified in: Health
Subjects: PDT, FDA

Eclipse Launches MicroPen EVOtm Advanced Microneedling Device


DALLAS, June 1, 2021 /PRNewswire/ -- Eclipse, a leading aesthetic and medical manufacturer, is pleased to announce FDA clearance of their latest medical-grade microneedling device, the MicroPen EVO. Successfully launched last year in Canada, the MicroPen EVO is now available to dermatology and aesthetic practices in the United States.

Microneedling is a procedure that uses small needles to create controlled injuries to the skin, promoting natural increases of collagen for the improvement of facial acne scarring. The new design and technology built into the MicroPen EVO will help practitioners treat patients more effectively, with more control, and an improved field of view.

"We are very excited to announce the FDA clearance of the MicroPen EVO," stated Tom O'Brien, CEO and Founder of Eclipse. "This represents the start of multigenerational product offerings that will propel Eclipse for many years to come."

The launch of the MicroPen EVO domestically has the aesthetic industry buzzing with anticipation. Dr. Paul Nassif of Nassif MD Plastic Surgery said, "As a long-time customer of Eclipse, I've appreciated their ability to innovate and improve the technologies we use every day. EVO is the next big thing." Dr. Joel Cohen, AboutSkin Dermatology and DermSurgery, echoed with, "I have been an Eclipse customer for a decade. I trust their products for my patients and my practice. Eclipse makes reliable products and the new MicroPen EVO clearance takes it all to a higher level."

Eclipse first entered the microneedling device industry with the MicroPen, widely regarded as the premier pen at the time of its launch. In 2015, the MicroPen Elite was released, introducing both form factor and technological improvements. Together, the two MicroPen products made Eclipse the industry leader in microneedling devices.

Now that MicroPen EVO has been cleared in the United States, Eclipse will be offering a special upgrade program exclusively for previous customers of their MicroPen Elite.

Dermatology and aesthetic providers looking for more information about the Eclipse MicroPen EVO or other Eclipse products, including Eclipse PRP® and VOTESSEtm hair health system, visit EclipseMed.com. To talk to an Eclipse representative, please call us at 800-759-6876 or email [email protected].

To see the MicroPen EVO now, click here.

About Eclipse
Eclipse was established in January 1993 as a specialty surgical supply company. It quickly became one of the pioneers in the aesthetic market, launching several energy-based devices in the United States. Today, Eclipse has a global presence and is one of the largest and most successful privately held medical device companies in its space.

EclipseMed.com

For more information, contact:
Dean Hensley
[email protected]

SOURCE Eclipse


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: